Nicergoline

Specifications

27848-84-6CAS Number

248-694-6EC Number

[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylateIUPAC Name

C24H26BrN3O3Chemical Formula

484.4 g/molMolecular Weight

nicergoline; 27848-84-6; Nicotergoline; Nimergoline; Sermion; ergobel; Nicergolina; cergodum; duracebrol; nicergolent; Nicergolinum; Vasospan; Ergotop; Memoq; Circo-Maren; Dilasenil; Nilogrin; DTXSID7045607; 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate; JCV8365FWN; FI-6714; NSC-150531; Circo Maren; DTXCID5025607; Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-; Nicergolin TEVA; [(2S,4R,7R)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]methyl 5-bromopyridine-3-carboxylate; Nicergolin ratiopharm; Von Ct, Nicergolin; Nicergolin neuraxpharm; ((8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl)methyl 5-bromopyridine-3-carboxylate; [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl 5-Bromopyridine-3-carboxylate; ((2S,4R,7R)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraen-4-yl)methyl 5-bromopyridine-3-carboxylate; RefChem:853815; C04AE02; 248-694-6; Nimergoline base; MFCD00869626; ((6AR,9R,10AS)-10A-METHOXY-4,7-DIMETHYL-4,6,6A,7,8,9,10,10A-OCTAHYDROINDOLO[4,3-FG]QUINOLIN-9-YL)METHYL 5-BROMONICOTINATE; C24H26BrN3O3; Sermion (TN); 10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate (ester); Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-,5-bromo-3-pyridinecarboxylate (ester), (8b)-; Nicergolin [German]; Nicergolina [DCIT]; RP 19651; NCGC00017259-04; Nicergolinum [INN-Latin]; Nicergolin; [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate; CAS-27848-84-6; FI 6714; 10-Methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat); 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester; SR-01000597616; EINECS 248-694-6; UNII-JCV8365FWN; NSC 150531; BRN 4828393; Nicotergoline;; Nimergoline;; Nargoline;; Nicergoline CRS; 1-Methyl-lumilysergol 8-(5-bromonicotinate) 10-methyl ether; Nicergoline(Rrs); (+)-10-Methoxy-1,6-dimethylergoline-8-beta-methanol 5-bromonicotinate; Nicergoline [USAN:INN:BAN:JAN]; 10-Methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat) [German]; 8-beta-((5-Bromonicotinoyloxy)methyl)-1,6-dimethyl-10-alpha-methoxyergoline; 10-Methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyrindinecarboxylate (ester); Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester); Nicergoline (Standard); Spectrum_001370; NICERGOLINE [MI]; Prestwick0_000147; Prestwick1_000147; Prestwick2_000147; Prestwick3_000147; Spectrum2_001414; Spectrum3_001933; Spectrum4_000440; Spectrum5_001352; NICERGOLINE [INN]; NICERGOLINE [JAN]; NICERGOLINE [USAN]; Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester); Ergoline-8beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester); Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, (8beta)-, 5-bromo-3-pyridinecarboxylate (ester); NICERGOLINE [MART.]; SCHEMBL22964; BSPBio_000254; BSPBio_003533; KBioGR_000800; KBioSS_001850; NICERGOLINE [WHO-DD]; DivK1c_000124; SPECTRUM1501133; SPBio_001488; SPBio_002193; BPBio1_000280; orb1309661; CHEMBL1372950; Nicergoline - Bio-X trade mark; SCHEMBL29561276; CHEBI:31902; HMS500G06; HY-B0702R; KBio1_000124; KBio2_001850; KBio2_004418; KBio2_006986; KBio3_002787; Nicergoline (JP18/USAN/INN); NINDS_000124; GLXC-07999; HMS1568M16; HMS1923O09; HMS2089I03; HMS2092F07; HMS2095M16; HMS3712M16; HMS3886C03; NICERGOLINE [EP MONOGRAPH]; Pharmakon1600-01501133; EX-A4135; HY-B0702; Tox21_110810; CCG-39032; EBC-27212; NSC757853; s4797; AKOS005067888; AKOS015969107; Nicergoline for system suitability CRS; Tox21_110810_1; DB00699; FB01518; Nicergoline 1.0 mg/ml in Acetonitrile; Nicergoline for peak identification CRS; NSC-757853; IDI1_000124; QTL1_000060; NCGC00017259-03; NCGC00017259-05; NCGC00017259-07; NCGC00024678-02; NCGC00024678-03; [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinoline-9-yl]methyl 5-bromopyridine-3-carboxylate; AS-12239; BN166697; ST055762; SY059965; SBI-0051652.P002; N0904; N3210; D01290; AB00052214-04; AB00052214_05; EN300-7361926; SR-05000001751; Nicergoline, analytical standard, for drug analysis; Q2623398; SR-01000597616-1; SR-01000597616-2; SR-05000001751-1; BRD-K76810206-001-05-7; BRD-K76810206-001-06-5; BRD-K76810206-001-07-3; BRD-K76810206-001-08-1; Nicergoline, European Pharmacopoeia (EP) Reference Standard; (10-Methoxy-1,6-dimethylergolin-8beta-yl)methyl 5-bromopyridine-3-carboxylate; (8beta)-10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyridinecarboxylate (ester); [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl 5-bromopyr idine-3-carboxylate; Nicergoline for peak identification, European Pharmacopoeia (EP) Reference Standard; Nicergoline for system suitability, European Pharmacopoeia (EP) Reference Standard; ((6AR,9R,10AS)-10A-METHOXY-4,7-DIMETHYL-4,6,6A,7,8,9,10,10A-OCTAHYDROINDOLO[4,3-FG]QUINOLIN-9-YL)METHYL5-BROMONICOTINATE; [(2S,4R,7R)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraen-4-yl]methyl 5-bromopyridine-3-carboxylate; 5-Bromopyridine-3-carboxylic Acid [(8R,10S)-10-Methoxy-1,6-dimethylergolin-8-yl]methyl Ester; ERGOLINE-8-METHANOL, 10-METHOXY-1,6-DIMETHYL-, (8.BETA.)-, 5-BROMO-3-PYRIDINECARBOXYLATE (ESTER)Synonyms